Stilits Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
- Paid Up Capital ₹ 2.00 M
- Company Age 7 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.00 M
- Satisfied Charges ₹ 4.00 M
- Revenue Growth 12.48%
- Profit Growth 15.54%
- Ebitda 13.06%
- Net Worth 38.42%
- Total Assets 29.84%
About Stilits Pharmaceuticals
Stilits Pharmaceuticals Private Limited (SPPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 05 December 2017 (Seven years and two months 11 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 2.00 M.
The company currently has active open charges totaling ₹5.00 M. The company has closed loans amounting to ₹4.00 M, as per Ministry of Corporate Affairs (MCA) records.
Bharatha Nageswararao and Naga Deepthi serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U51909MH2017PTC302454
-
Company No.
302454
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
05 Dec 2017
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Stilits Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Naga Deepthi
|
Managing Director | 05-Dec-2017 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Bharatha Nageswararao
|
Director | 22-Feb-2018 | Current |
Financial Performance of Stilits Pharmaceuticals.
Stilits Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 12.48% increase. The company also saw a substantial improvement in profitability, with a 15.54% increase in profit. The company's net worth Soared by an impressive increase of 38.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Stilits Pharmaceuticals?
Unlock access to Stilits Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹5.00 M
₹4.00 M
Charges Breakdown by Lending Institutions
- Others : 0.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Mar 2024 | Others | ₹5.00 M | Open |
| 27 May 2021 | Others | ₹2.00 M | Satisfied |
| 24 May 2018 | State Bank Of India | ₹2.00 M | Satisfied |
How Many Employees Work at Stilits Pharmaceuticals?
Unlock and access historical data on people associated with Stilits Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Stilits Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Stilits Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
